Chemotherapy News and Research

Latest Chemotherapy News and Research

Experimental drug outperforms standard first-line therapy for advanced kidney cancer patients

An experimental kidney cancer drug outperformed the standard first-line therapy for patients with metastatic disease who are considered at risk for poorer than average outcomes, according to results of a randomized phase II clinical trial by researchers at Dana-Farber Cancer Institute.

15 Nov 2016

Researchers find new therapeutic target of biomedical interest in ischemic injury research

An international scientific team has developed a new small molecule -VH298- which can provoke a hypoxic response controlled from outside the cells, according to a study recently published in the magazine Nature Communications with its first authors being the expert Carles Galdeano, Beatriu de Pinós researcher at the Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry of the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine of the University of Barcelona, and Julianty Frost, from the University of Dundee.

15 Nov 2016

Cancer researchers identify important driver of tumor cell invasion in glioblastoma

University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.

15 Nov 2016

Study shows how comorbid mental health conditions can impact child's care in hospital

Children hospitalized for medical or surgical procedures who have an existing mental health condition stay in the hospital longer than children without these conditions.

14 Nov 2016

New guidelines provide recommendations on HER2 testing for patients with gastroesophageal cancers

The College of American Pathologists, the American Society for Clinical Pathology, and the American Society of Clinical Oncology today released an evidence-based clinical practice guideline on human epidermal growth factor receptor 2 (HER2) testing for patients with gastroesophageal cancers.

14 Nov 2016

Virginia Tech and CytImmune Sciences develop more effective and less toxic cancer treatment

Virginia Tech scientists have developed a new cancer drug that uses gold nanoparticles created by the biotech firm CytImmune Sciences to deliver paclitaxel — a commonly used chemotherapy drug directly to a tumor.

14 Nov 2016

New discovery may lead to better treatment options for pancreatic cancer patients

Pancreatic cancer, the third leading cause of cancer-related deaths, is projected to be the second by the year 2030, according to a study in the journal of Cancer Research.

11 Nov 2016

Moffitt scientists show how mathematical modeling can predict patient responses to cancer drugs

Scientists have significantly improved their understanding of cancer and have developed numerous therapies that have helped to reduce patient mortality; however, the majority of drugs that make it to the clinical trial phase of development fail, despite promising data in laboratory studies.

11 Nov 2016

CHLA researchers receive TRP grant to study new way of combating relapsed ALL

Yong-Mi Kim, MD, PhD, of The Saban Research Institute of Children's Hospital Los Angeles, has been awarded a 3 year translational research program grant from the Leukemia & Lymphoma Society to study a novel approach to eradicating minimal residual disease in patients with acute lymphoblastic leukemia (ALL).

10 Nov 2016

Healthcare support worker explains benefits of scalp cooling for cancer patients

A healthcare support worker, who supports cancer patients throughout their chemotherapy journeys, has spoken out about the benefits of scalp cooling and what it means to the people who use it.

From Paxman 10 Nov 2016

Agendia partners with Cryogene and Mist to distribute breast cancer recurrence assay in the Middle East

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announced today a partnership agreement to distribute the company’s breast cancer recurrence assay, MammaPrint, in the Middle East.

10 Nov 2016

SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

SMU virologist and cancer researcher Robert L. Harrod has been awarded a $436,500 grant from the National Cancer Institute to further his lab's research into how certain viruses cause cancers in humans.

8 Nov 2016

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

One of the worst cruelties of lethal cancer is the phenomenon called wasting, or in medical terms, cachexia (pronounced ka-CHEX-ia), in which a patient seems literally to diminish in bodily terms as the cancer ravages one or more internal organs.

8 Nov 2016

Tailored dose-dense chemotherapy does not improve breast cancer recurrence-free survival

Among women with high-risk early breast cancer, the use of tailored dose-dense chemotherapy compared with standard adjuvant chemotherapy did not result in a statistically significant improvement in breast cancer recurrence-free survival, and nonhematologic toxic effects were more frequent in the tailored dose-dense group, according to a study appearing in the November 8 issue of JAMA.

8 Nov 2016

Researchers develop new strategy to immunize against microbes that cause foodborne illness

University of California, Irvine and MIT researchers have developed a new strategy to immunize against microbes that invade the gastrointestinal tract, including Salmonella, which causes more foodborne illness in the United States than any other bacteria.

8 Nov 2016

Study finds lack of improvement in health status of childhood cancer survivors

Long-term survivors of childhood cancer live longer thanks to improvements to cancer treatments, but a new study looking at three decades of therapy suggests patients do not report better health status.

8 Nov 2016

Scientists develop new computer-based method to assess cell communication networks

A multi-institution academic-industrial partnership of researchers led by Case Western Reserve University School of Medicine has developed a new method to broadly assess cell communication networks and identify disease-specific network anomalies.

8 Nov 2016

Suppressing bone specific protein can alleviate radiotherapy-induced osteoporosis

Radiotherapy destroys cancer cells using high-energy ionizing radiation to damage DNA and induce cell death. About two million patients per year in the United States - more than 50 percent of all cancer patients -- receive radiotherapy at some stage during their illness, either alone or in combination with chemotherapy, surgery, and targeted medicines.

7 Nov 2016

New treatment with therapeutic short interfering RNA could help thwart cancer

In the fight against cancer, doctors dish out combination-blows of surgery, chemotherapy and other drugs to beat back a merciless foe. Now, scientists have taken early steps toward adding a stinging punch to clinicians' repertoire.

7 Nov 2016

Combination of immunotherapy treatments can improve survival in patients with advanced skin cancer

McMaster University researchers have found that for patients diagnosed in the late stages of one of the most common and deadly forms of skin cancer, treatment with a combination of immunotherapy options improves survival and lowers the risk of life-threatening events.

7 Nov 2016

Chemotherapy News and Research

Latest Chemotherapy News and Research

Experimental drug outperforms standard first-line therapy for advanced kidney cancer patients

Researchers find new therapeutic target of biomedical interest in ischemic injury research

Cancer researchers identify important driver of tumor cell invasion in glioblastoma

Study shows how comorbid mental health conditions can impact child's care in hospital

New guidelines provide recommendations on HER2 testing for patients with gastroesophageal cancers

Virginia Tech and CytImmune Sciences develop more effective and less toxic cancer treatment

New discovery may lead to better treatment options for pancreatic cancer patients

Moffitt scientists show how mathematical modeling can predict patient responses to cancer drugs

CHLA researchers receive TRP grant to study new way of combating relapsed ALL

Healthcare support worker explains benefits of scalp cooling for cancer patients

Agendia partners with Cryogene and Mist to distribute breast cancer recurrence assay in the Middle East

SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

Tailored dose-dense chemotherapy does not improve breast cancer recurrence-free survival

Researchers develop new strategy to immunize against microbes that cause foodborne illness

Study finds lack of improvement in health status of childhood cancer survivors

Scientists develop new computer-based method to assess cell communication networks

Suppressing bone specific protein can alleviate radiotherapy-induced osteoporosis

New treatment with therapeutic short interfering RNA could help thwart cancer

Combination of immunotherapy treatments can improve survival in patients with advanced skin cancer

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in